These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 26432911)
1. Is immunotherapy an opportunity for effective treatment of drug addiction? Zalewska-Kaszubska J Vaccine; 2015 Nov; 33(48):6545-51. PubMed ID: 26432911 [TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for the treatment of drug abuse. Kosten T; Owens SM Pharmacol Ther; 2005 Oct; 108(1):76-85. PubMed ID: 16023218 [TBL] [Abstract][Full Text] [Related]
3. Ethical Implications in Vaccine Pharmacotherapy for Treatment and Prevention of Drug of Abuse Dependence. Carfora A; Cassandro P; Feola A; La Sala F; Petrella R; Borriello R J Bioeth Inq; 2018 Mar; 15(1):45-55. PubMed ID: 29350320 [TBL] [Abstract][Full Text] [Related]
4. [Advances in Immunotherapy for Drug Addiction]. Chen L; Ru Q; Zhou M; Wu YX Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Feb; 43(1):116-123. PubMed ID: 33663672 [TBL] [Abstract][Full Text] [Related]
5. Anti-drug vaccines to treat substance abuse. Kinsey BM; Jackson DC; Orson FM Immunol Cell Biol; 2009; 87(4):309-14. PubMed ID: 19333250 [TBL] [Abstract][Full Text] [Related]
6. Animal Models and the Development of Vaccines to Treat Substance Use Disorders. Ohia-Nwoko O; Kosten TA; Haile CN Int Rev Neurobiol; 2016; 126():263-91. PubMed ID: 27055616 [TBL] [Abstract][Full Text] [Related]
13. Development of active and passive human vaccines to treat methamphetamine addiction. Gentry WB; RĂ¼edi-Bettschen D; Owens SM Hum Vaccin; 2009 Apr; 5(4):206-13. PubMed ID: 19276653 [TBL] [Abstract][Full Text] [Related]
14. Development of immunopharmacotherapy against drugs of abuse. Meijler MM; Matsushita M; Wirsching P; Janda KD Curr Drug Discov Technol; 2004 Jan; 1(1):77-89. PubMed ID: 16472221 [TBL] [Abstract][Full Text] [Related]
15. Current status of immunotherapies for addiction. Xu A; Kosten TR Ann N Y Acad Sci; 2021 Apr; 1489(1):3-16. PubMed ID: 32147860 [TBL] [Abstract][Full Text] [Related]
16. Development of vaccines to help treat drug dependence. Bunce CJ; Loudon PT; Akers C; Dobson J; Wood DM Curr Opin Mol Ther; 2003 Feb; 5(1):58-63. PubMed ID: 12669472 [TBL] [Abstract][Full Text] [Related]
17. Combined active and passive immunization against nicotine: minimizing monoclonal antibody requirements using a target antibody concentration strategy. Cornish KE; Harris AC; LeSage MG; Keyler DE; Burroughs D; Earley C; Pentel PR Int Immunopharmacol; 2011 Nov; 11(11):1809-15. PubMed ID: 21802529 [TBL] [Abstract][Full Text] [Related]
18. Biotechnology and the treatment of addictive disorders: new opportunities. Elkashef A; Biswas J; Acri JB; Vocci F BioDrugs; 2007; 21(4):259-67. PubMed ID: 17628123 [TBL] [Abstract][Full Text] [Related]
19. A morphine/heroin vaccine with new hapten design attenuates behavioral effects in rats. Li QQ; Luo YX; Sun CY; Xue YX; Zhu WL; Shi HS; Zhai HF; Shi J; Lu L J Neurochem; 2011 Dec; 119(6):1271-81. PubMed ID: 21951213 [TBL] [Abstract][Full Text] [Related]
20. [Vaccinations in psychiatry]. Dols A; van den Brink W; Eikelenboom P Tijdschr Psychiatr; 2009; 51(10):751-9. PubMed ID: 19821243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]